Skip to content

Clinical trials

Phase 3 Clostridium Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Clostridium Infections Phase: Phase 3 Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20064
20101
20112
20123
20133
20141
20153
20161
20174
20181
20193
20201
20213
20222
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Unknown status4
Recruiting3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Actelion2
Bio-K Plus International Inc.2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
McMaster University2
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
Rebiotix Inc.2
Seres Therapeutics, Inc.2
Summit Therapeutics2
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Clostridium Infections38
Diarrhea12
Infections3
Communicable Diseases2
Enterocolitis, Pseudomembranous2
Digestive System Diseases1
Dysentery1
Gastroenteritis1
Gastrointestinal Diseases1
Gram-Positive Bacterial Infections1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.